A phase II study of 4-deoxydoxorubicin in advanced breast cancer.
Rankin
E M
EM
Knight
R K
RK
Rubens
R D
RD
D001943:Breast Neoplasms / Q000188:drug therapy*; D004317:Doxorubicin / Q000031:analogs & derivatives* / Q000627:therapeutic use; D004341:Drug Evaluation; D006801:Humans
D004317:Doxorubicin; C030851:esorubicin